Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A8,8 | Lung | Primary cancer | 2,518 | Stromal | 34.3% | 0.83 | 0.45 |
| NSCLC_38242124__IMC__87_A8,9 | Lung | Primary cancer | 2,976 | Tumor/Malignant | 76.6% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__87_B1,1 | Lung | Primary cancer | 2,500 | Tumor/Malignant | 75.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B1,10 | Lung | Primary cancer | 3,058 | Tumor/Malignant | 84.2% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__87_B1,11 | Lung | Primary cancer | 2,689 | Tumor/Malignant | 65.4% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_B1,12 | Lung | Primary cancer | 2,296 | Tumor/Malignant | 66.2% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__87_B1,13 | Lung | Primary cancer | 3,976 | Tumor/Malignant | 56.3% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__87_B1,14 | Lung | Primary cancer | 3,324 | Tumor/Malignant | 34.8% | 0.92 | 0.24 |
| NSCLC_38242124__IMC__87_B1,15 | Lung | Primary cancer | 1,374 | Stromal | 31.2% | 0.41 | 1.02 |
| NSCLC_38242124__IMC__87_B1,16 | Lung | Primary cancer | 1,351 | Tumor/Malignant | 80.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B1,17 | Lung | Primary cancer | 3,171 | Stromal | 29.2% | 0.51 | 0.83 |
| NSCLC_38242124__IMC__87_B1,2 | Lung | Primary cancer | 3,919 | Tumor/Malignant | 34.5% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__87_B1,3 | Lung | Primary cancer | 2,577 | Tumor/Malignant | 62.9% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__87_B1,4 | Lung | Primary cancer | 2,857 | Tumor/Malignant | 59.7% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__87_B1,5 | Lung | Primary cancer | 2,602 | Tumor/Malignant | 40.7% | 0.85 | 0.35 |
| NSCLC_38242124__IMC__87_B1,6 | Lung | Primary cancer | 513 | Tumor/Malignant | 55.6% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__87_B1,7 | Lung | Primary cancer | 3,546 | Tumor/Malignant | 67.2% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B1,8 | Lung | Primary cancer | 2,515 | Stromal | 30.7% | 0.54 | 0.86 |
| NSCLC_38242124__IMC__87_B1,9 | Lung | Primary cancer | 3,200 | Tumor/Malignant | 39.8% | 0.76 | 0.52 |
| NSCLC_38242124__IMC__87_B2,1 | Lung | Primary cancer | 2,416 | Tumor/Malignant | 76.6% | 0.99 | 0.07 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A8,8 | Lung | Primary cancer | 2,518 | Tumor/Malignant | 28.0% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__87_A8,9 | Lung | Primary cancer | 2,976 | Tumor/Malignant | 54.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_B1,1 | Lung | Primary cancer | 2,500 | Tumor/Malignant | 67.6% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_B1,10 | Lung | Primary cancer | 3,058 | Tumor/Malignant | 81.9% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B1,11 | Lung | Primary cancer | 2,689 | Tumor/Malignant | 60.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_B1,12 | Lung | Primary cancer | 2,296 | Tumor/Malignant | 54.7% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B1,13 | Lung | Primary cancer | 3,976 | Tumor/Malignant | 39.1% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__87_B1,14 | Lung | Primary cancer | 3,324 | Tumor/Malignant | 29.2% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_B1,15 | Lung | Primary cancer | 1,374 | Stromal | 35.0% | 0.35 | 1.04 |
| NSCLC_38242124__IMC__87_B1,16 | Lung | Primary cancer | 1,351 | Tumor/Malignant | 59.0% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B1,17 | Lung | Primary cancer | 3,171 | Stromal | 25.4% | 0.50 | 0.95 |
| NSCLC_38242124__IMC__87_B1,2 | Lung | Primary cancer | 3,919 | Tumor/Malignant | 32.7% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__87_B1,3 | Lung | Primary cancer | 2,577 | Tumor/Malignant | 62.8% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__87_B1,4 | Lung | Primary cancer | 2,857 | Tumor/Malignant | 54.0% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B1,5 | Lung | Primary cancer | 2,602 | Tumor/Malignant | 33.9% | 0.90 | 0.27 |
| NSCLC_38242124__IMC__87_B1,6 | Lung | Primary cancer | 513 | Tumor/Malignant | 56.3% | 0.94 | 0.20 |
| NSCLC_38242124__IMC__87_B1,7 | Lung | Primary cancer | 3,546 | Tumor/Malignant | 61.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B1,8 | Lung | Primary cancer | 2,515 | Stromal | 23.8% | 0.56 | 0.91 |
| NSCLC_38242124__IMC__87_B1,9 | Lung | Primary cancer | 3,200 | Tumor/Malignant | 37.8% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B2,1 | Lung | Primary cancer | 2,416 | Tumor/Malignant | 67.8% | 1.00 | 0.01 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A8,8 | Lung | Primary cancer | 2,518 | Fibroblast | 33.2% | 0.82 | 0.48 |
| NSCLC_38242124__IMC__87_A8,9 | Lung | Primary cancer | 2,976 | Tumor/Malignant cell | 75.1% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__87_B1,1 | Lung | Primary cancer | 2,500 | Tumor/Malignant cell | 76.0% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__87_B1,10 | Lung | Primary cancer | 3,058 | Tumor/Malignant cell | 82.3% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_B1,11 | Lung | Primary cancer | 2,689 | Tumor/Malignant cell | 65.1% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_B1,12 | Lung | Primary cancer | 2,296 | Tumor/Malignant cell | 67.5% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_B1,13 | Lung | Primary cancer | 3,976 | Tumor/Malignant cell | 59.6% | 0.90 | 0.27 |
| NSCLC_38242124__IMC__87_B1,14 | Lung | Primary cancer | 3,324 | Tumor/Malignant cell | 35.7% | 0.91 | 0.26 |
| NSCLC_38242124__IMC__87_B1,15 | Lung | Primary cancer | 1,374 | Tumor/Malignant cell | 28.0% | 0.62 | 0.81 |
| NSCLC_38242124__IMC__87_B1,16 | Lung | Primary cancer | 1,351 | Tumor/Malignant cell | 80.2% | 0.99 | 0.04 |
| NSCLC_38242124__IMC__87_B1,17 | Lung | Primary cancer | 3,171 | Fibroblast | 23.6% | 0.75 | 0.62 |
| NSCLC_38242124__IMC__87_B1,2 | Lung | Primary cancer | 3,919 | Tumor/Malignant cell | 35.0% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__87_B1,3 | Lung | Primary cancer | 2,577 | Tumor/Malignant cell | 62.9% | 0.95 | 0.19 |
| NSCLC_38242124__IMC__87_B1,4 | Lung | Primary cancer | 2,857 | Tumor/Malignant cell | 60.9% | 0.97 | 0.11 |
| NSCLC_38242124__IMC__87_B1,5 | Lung | Primary cancer | 2,602 | Tumor/Malignant cell | 41.9% | 0.85 | 0.38 |
| NSCLC_38242124__IMC__87_B1,6 | Lung | Primary cancer | 513 | Tumor/Malignant cell | 55.6% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__87_B1,7 | Lung | Primary cancer | 3,546 | Tumor/Malignant cell | 67.1% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_B1,8 | Lung | Primary cancer | 2,515 | Fibroblast | 32.0% | 0.71 | 0.72 |
| NSCLC_38242124__IMC__87_B1,9 | Lung | Primary cancer | 3,200 | Tumor/Malignant cell | 63.7% | 0.89 | 0.29 |
| NSCLC_38242124__IMC__87_B2,1 | Lung | Primary cancer | 2,416 | Tumor/Malignant cell | 76.9% | 0.99 | 0.07 |